A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas

“…A second malignancy occurred in one case. (Gospodarowicz et al, 1983;Fleming et al, 1982;Paulson et al, 1983;Herrera et al, 1985;Dragosics et al, 1985;Ampil, 1987;Rosenfelt & Rosemberg, 1980;Economopoulos et al, 1985;Sheridan et al, 1985;Liang et al, 1987;Steward et al, 1985;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988). Our study indicates that chemotherapy following surgical resection of gastrointestinal lymphomas is highly effective: we obtained 81% CRs in patients treated with partial or palliative resection, and an overall 76% 10-year causespecific survival, which are results comparable with those of other recently published reports (Paulson et al, 1983;Sheridan et al, 1985;Liang et al, 1987;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988).…”

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas

“…A second malignancy occurred in one case. (Gospodarowicz et al, 1983;Fleming et al, 1982;Paulson et al, 1983;Herrera et al, 1985;Dragosics et al, 1985;Ampil, 1987;Rosenfelt & Rosemberg, 1980;Economopoulos et al, 1985;Sheridan et al, 1985;Liang et al, 1987;Steward et al, 1985;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988). Our study indicates that chemotherapy following surgical resection of gastrointestinal lymphomas is highly effective: we obtained 81% CRs in patients treated with partial or palliative resection, and an overall 76% 10-year causespecific survival, which are results comparable with those of other recently published reports (Paulson et al, 1983;Sheridan et al, 1985;Liang et al, 1987;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988).…”

Therapeutic Management of Stage I–II High-Grade Primary Gastric Lymphomas

“…The risk, however, was overestimated because primary chemotherapy in surgical series was reserved for cases with stage IV disease, unresectable lesion or intestinal lymphoma, which have an increased intrinsic risk of bleeding or perforation [1, 3, 6, 7]. In the present series, no patient treated with the conservative strategy suffered from bleeding or perforation.…”

Papel de la cirugía en el tratamiento del linfoma gástrico primario

“…Existen múltiples referencias en la li te ratura acerca del comportamiento y manejo de estos tumores. Sin embargo, debido a su escasa .incidencia son pocos los estudios prospectivos randomizados realizados (18)(19)(20). La variedad existente de clasificaciones, tanto histológicas como de estadificación, dificulta la concreción a la hora de defin ir una estrategia de tratamiento.…”

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas

“…A second malignancy occurred in one case. (Gospodarowicz et al, 1983;Fleming et al, 1982;Paulson et al, 1983;Herrera et al, 1985;Dragosics et al, 1985;Ampil, 1987;Rosenfelt & Rosemberg, 1980;Economopoulos et al, 1985;Sheridan et al, 1985;Liang et al, 1987;Steward et al, 1985;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988). Our study indicates that chemotherapy following surgical resection of gastrointestinal lymphomas is highly effective: we obtained 81% CRs in patients treated with partial or palliative resection, and an overall 76% 10-year causespecific survival, which are results comparable with those of other recently published reports (Paulson et al, 1983;Sheridan et al, 1985;Liang et al, 1987;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988).…”

Therapeutic Management of Stage I–II High-Grade Primary Gastric Lymphomas

“…The risk, however, was overestimated because primary chemotherapy in surgical series was reserved for cases with stage IV disease, unresectable lesion or intestinal lymphoma, which have an increased intrinsic risk of bleeding or perforation [1, 3, 6, 7]. In the present series, no patient treated with the conservative strategy suffered from bleeding or perforation.…”

Papel de la cirugía en el tratamiento del linfoma gástrico primario

“…Existen múltiples referencias en la li te ratura acerca del comportamiento y manejo de estos tumores. Sin embargo, debido a su escasa .incidencia son pocos los estudios prospectivos randomizados realizados (18)(19)(20). La variedad existente de clasificaciones, tanto histológicas como de estadificación, dificulta la concreción a la hora de defin ir una estrategia de tratamiento.…”

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas

“…A second malignancy occurred in one case. (Gospodarowicz et al, 1983;Fleming et al, 1982;Paulson et al, 1983;Herrera et al, 1985;Dragosics et al, 1985;Ampil, 1987;Rosenfelt & Rosemberg, 1980;Economopoulos et al, 1985;Sheridan et al, 1985;Liang et al, 1987;Steward et al, 1985;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988). Our study indicates that chemotherapy following surgical resection of gastrointestinal lymphomas is highly effective: we obtained 81% CRs in patients treated with partial or palliative resection, and an overall 76% 10-year causespecific survival, which are results comparable with those of other recently published reports (Paulson et al, 1983;Sheridan et al, 1985;Liang et al, 1987;Janus et al, 1984;List et al, 1988;Shepherd et al, 1988).…”

Therapeutic Management of Stage I–II High-Grade Primary Gastric Lymphomas

“…The risk, however, was overestimated because primary chemotherapy in surgical series was reserved for cases with stage IV disease, unresectable lesion or intestinal lymphoma, which have an increased intrinsic risk of bleeding or perforation [1, 3, 6, 7]. In the present series, no patient treated with the conservative strategy suffered from bleeding or perforation.…”

Papel de la cirugía en el tratamiento del linfoma gástrico primario

“…Existen múltiples referencias en la li te ratura acerca del comportamiento y manejo de estos tumores. Sin embargo, debido a su escasa .incidencia son pocos los estudios prospectivos randomizados realizados (18)(19)(20). La variedad existente de clasificaciones, tanto histológicas como de estadificación, dificulta la concreción a la hora de defin ir una estrategia de tratamiento.…”